Economic Burden of Endometriosis: A Systematic Review and Meta-Analysis
Author:
Open Access
- 2 December 2024
- journal article
- review article
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 3 (3) , 304-319
Abstract
Introduction: Endometriosis, marked by uterine-like tissue growth outside the uterus, causes severe pelvic pain and infertility. Delayed diagnosis contributes to its significant global economic burden, especially in Europe and the USA. Despite treatment advances, managing endometriosis remains challenging. Comprehensive strategies are urgently needed to reduce its economic impact and improve patient outcomes. Material and Methods: We searched for English-language full-text literature from PubMed, Cochrane, Wiley Library, and ScienceDirect databases from January 2013 to January 2024. Total of 951 studies were identified, and 14 studies were included, providing comprehensive data on the economic burden of endometriosis, including direct healthcare costs and productivity losses. Results: The economic burden of endometriosis, based on 14 studies, is substantial, reflecting both direct healthcare costs and productivity losses. Average annual costs per woman ranged from EUR 8,768 in Sweden to Int $16,970-$20,898 in Australia. Non-surgical treatments in the USA were more cost-effective than surgery, costing $100,000 per QALY. In the UK, the LNG-IUS was the most expensive treatment at £650.94. Costs in China for various therapies ranged up to $10,728 with differing ICERs. Conclusion: These findings underscore the significant economic impact and the need for cost-effective management strategies: costs and productivity losses. Effective management strategies are essential to mitigate these costs.Keywords
This publication has 27 references indexed in Scilit:
- Understanding diagnostic delay for endometriosis: A scoping review using the social-ecological frameworkHealth Care for Women International, 2024
- Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and CostsAdvances in Therapy, 2020
- Clinical diagnosis of endometriosis: a call to actionAmerican Journal of Obstetrics and Gynecology, 2019
- Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United StatesAdvances in Therapy, 2018
- Endometriosis: Epidemiology, Diagnosis and Clinical ManagementCurrent Obstetrics and Gynecology Reports, 2017
- Economic burden of deep infiltrating endometriosis of the bowel and the bladder in Germany: The statutory health insurance perspectiveZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2016
- The direct and indirect costs associated with endometriosis: a systematic literature reviewHuman Reproduction, 2016
- Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databasesFertility and Sterility, 2015
- Cost-Effectiveness Analysis of the Therapy of EndometriosisValue in Health, 2014
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countriesFertility and Sterility, 2011